Reduced p21WAF1/CIP1 expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder
2001; Elsevier BV; Volume: 32; Issue: 8 Linguagem: Inglês
10.1053/hupa.2001.26474
ISSN1532-8392
AutoresXin Li, Ai‐Min Hui, Ya-Zhou Shi, Tadatoshi Takayama, Masatoshi Makuuchi,
Tópico(s)RNA modifications and cancer
ResumoThe molecular basis underlying the development and progression of gallbladder carcinoma (GBC) remains poorly understood. To evaluate the roles of p21WAF1/CIP1 and p53 in gallbladder carcinogenesis and to assess their prognostic significance for patients with GBC, we used immunohistochemistry to examine the expression of p21WAF1/CIP1 and p53 protein in a series of surgically resected specimens, including normal epithelia, precancerous lesions adenoma, and dysplasia, and carcinomas of the gallbladder. Reduced p21WAF1/CIP1 expression was frequently observed in carcinomas (18 of 37 lesions; 49%), and even in precancerous lesions adenomas (3 of 7; 43%) and dysplasias (5 of 5; 100%). p53 overexpression was detected in 43% of the adenomas, 60% of the dysplasias and 57% of the carcinomas. There was an inverse relationship between p21WAF1/CIP1 and p53 expression in GBCs (P = .01). Survival analysis indicated that reduced p21WAF1/CIP1 expression was significantly associated with shortened disease-free and overall survival (P = .04 and .03, respectively) for patients with stages II to IV GBCs. These observations suggest that reduced p21WAF1/CIP1 expression and p53 overexpression contribute to GBC from an early stage and that determination of p21WAF1/CIP1 expression in surgically resected specimens would add prognostic information to conventional pathologic examinations for patients with advanced-stage GBC. HUM PATHOL 32:771-777. Copyright © 2001 by W.B. Saunders Company
Referência(s)